X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12267) 12267
Publication (994) 994
Book Review (187) 187
Newsletter (178) 178
Book Chapter (69) 69
Newspaper Article (37) 37
Conference Proceeding (28) 28
Magazine Article (27) 27
Transcript (11) 11
Book / eBook (8) 8
Dissertation (7) 7
Reference (4) 4
Web Resource (2) 2
Data Set (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8117) 8117
index medicus (6325) 6325
male (4658) 4658
animals (4633) 4633
glucagon-like peptide-1 (4060) 4060
glucagon (3871) 3871
endocrinology & metabolism (3471) 3471
female (3274) 3274
diabetes mellitus, type 2 - drug therapy (2978) 2978
diabetes (2843) 2843
insulin (2589) 2589
hypoglycemic agents - therapeutic use (2573) 2573
type 2 diabetes (2565) 2565
glucose (2416) 2416
middle aged (2206) 2206
adult (1960) 1960
blood glucose - metabolism (1796) 1796
pharmacology & pharmacy (1752) 1752
rats (1663) 1663
mice (1637) 1637
insulin - metabolism (1352) 1352
insulin - blood (1328) 1328
peptides (1306) 1306
aged (1289) 1289
diabetes mellitus (1284) 1284
glucagon - therapeutic use (1268) 1268
glp-1 (1257) 1257
obesity (1195) 1195
glucagon - blood (1180) 1180
liraglutide (1150) 1150
glucagon-like peptide 1 (1142) 1142
insulin - therapeutic use (1088) 1088
glycemic control (1057) 1057
analysis (1055) 1055
dextrose (1034) 1034
diabetes mellitus, type 2 - blood (1007) 1007
insulin secretion (1004) 1004
research (1001) 1001
insulin resistance (953) 953
hypoglycemic agents - pharmacology (946) 946
secretion (924) 924
care and treatment (906) 906
physiological aspects (898) 898
treatment outcome (883) 883
glucagon-like peptide 1 - therapeutic use (878) 878
glucagon-like peptide 1 - analogs & derivatives (871) 871
diabetes mellitus, type 2 - metabolism (866) 866
exenatide (847) 847
hyperglycemia (847) 847
internal medicine (844) 844
blood glucose - drug effects (834) 834
peptides - therapeutic use (797) 797
glucagon - metabolism (781) 781
metabolism (781) 781
dipeptidyl-peptidase iv inhibitors - therapeutic use (775) 775
glucagon-like peptide-1 receptor (775) 775
hypoglycemic agents - administration & dosage (772) 772
medicine & public health (758) 758
glucagon-like peptide 1 - metabolism (755) 755
health aspects (754) 754
rodents (754) 754
diabetes therapy (753) 753
blood glucose - analysis (718) 718
hypoglycemic agents - adverse effects (713) 713
glucose metabolism (693) 693
metformin (692) 692
hypoglycemic agents (683) 683
drug therapy (661) 661
abridged index medicus (657) 657
hypoglycemia (657) 657
double-blind (652) 652
beta-cell function (632) 632
biochemistry & molecular biology (620) 620
risk factors (619) 619
physiology (615) 615
type-2 diabetes-mellitus (611) 611
glucose - metabolism (605) 605
body weight (600) 600
time factors (591) 591
drug therapy, combination (581) 581
glucose tolerance test (581) 581
insulin-secretion (579) 579
endocrine system (578) 578
medicine, general & internal (578) 578
venoms - therapeutic use (574) 574
pancreas (571) 571
article (555) 555
glucagon - pharmacology (537) 537
diabetes mellitus, type 1 - drug therapy (535) 535
mice, inbred c57bl (535) 535
peptides - pharmacology (535) 535
diabetes mellitus, type 2 - physiopathology (519) 519
medicine, research & experimental (510) 510
double-blind method (509) 509
expression (509) 509
digestive, oral, and skin physiology (507) 507
medicine (506) 506
adolescent (501) 501
exendin-4 (501) 501
receptors, glucagon - agonists (498) 498
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11819) 11819
German (185) 185
French (117) 117
Italian (97) 97
Japanese (81) 81
Spanish (58) 58
Russian (47) 47
Polish (39) 39
Chinese (25) 25
Czech (18) 18
Danish (17) 17
Hungarian (12) 12
Norwegian (9) 9
Portuguese (8) 8
Swedish (8) 8
Dutch (6) 6
Romanian (6) 6
Finnish (5) 5
Korean (3) 3
Bulgarian (2) 2
Croatian (2) 2
Hebrew (2) 2
Lithuanian (2) 2
Serbian (2) 2
Arabic (1) 1
Bosnian (1) 1
Slovak (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, ISSN 1422-0067, 08/2019, Volume 20, Issue 15, p. 3646
Episodes of hypoglycemia are frequent in patients with diabetes treated with insulin or sulphonylureas. Hypoglycemia can lead to severe acute complications,... 
DEXTROSE | insulin | HEALTHY-SUBJECTS | BIOCHEMISTRY & MOLECULAR BIOLOGY | NASAL GLUCAGON | diabetes mellitus | CHEMISTRY, MULTIDISCIPLINARY | CALCITONIN | DELIVERY | CHILDREN | EMERGENCY-DEPARTMENT | hypoglycemia | FREQUENCY | glucagon | intranasal | TYPE-1
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 2011, Volume 33, Issue 7, pp. 793 - 811
Journal Article
European Heart Journal, ISSN 0195-668X, 09/2015, Volume 36, Issue 34, pp. 2288 - 2296
Journal Article
Best Practice & Research: Clinical Endocrinology & Metabolism, ISSN 1521-690X, 2007, Volume 21, Issue 4, pp. 517 - 533
Inhibition of dipeptidyl peptidase 4 (DPP-4) is a novel treatment for type-2 diabetes. DPP-4 inhibition prevents the inactivation of glucagon-like peptide 1... 
Endocrinology & Metabolism | treatment | dipeptidyl peptidase 4 | sitagliptin | type-2 diabetes | vildagliptin | glucagon-like peptide-1 | DIPEPTIDYL-PEPTIDASE-IV | INSULIN-SECRETION | INCRETIN HORMONES | IMPROVED GLUCOSE-TOLERANCE | BETA-CELL FUNCTION | METFORMIN-TREATED PATIENTS | IMPROVES GLYCEMIC CONTROL | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | TYPE-2 DIABETES-MELLITUS | Triazoles - adverse effects | Metformin - therapeutic use | Humans | Body Weight - drug effects | Pyrrolidines - adverse effects | Substrate Specificity | Glucagon-Like Peptide 1 - physiology | Pyrazines - therapeutic use | Pyrrolidines - therapeutic use | Thiazolidinediones - therapeutic use | Adamantane - therapeutic use | Sitagliptin Phosphate | Drug Therapy, Combination | Hypoglycemia - chemically induced | Protease Inhibitors - therapeutic use | Insulin Secretion | Adamantane - adverse effects | Adamantane - analogs & derivatives | Triazoles - therapeutic use | Hypoglycemic Agents - therapeutic use | Pioglitazone | Insulin - metabolism | Animals | Dipeptidyl-Peptidase IV Inhibitors | Lipid Metabolism - drug effects | Pyrazines - adverse effects | Glucagon - metabolism | Vildagliptin | Glucagon-Like Peptide 1 - antagonists & inhibitors | Diabetes Mellitus, Type 2 - drug therapy | Nitriles - adverse effects | Insulin - therapeutic use | Nitriles - therapeutic use | Clinical Medicine | Other Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Adamantane/adverse effects Adamantane/analogs & derivatives Adamantane/therapeutic use Animals Antigens | Annan klinisk medicin | Combination Glucagon/secretion Glucagon-Like Peptide 1/antagonists & inhibitors Glucagon-Like Peptide 1/physiology Humans Hypoglycemia/chemically induced Hypoglycemic Agents/therapeutic use Insulin/secretion Insulin/therapeutic use Lipid Metabolism/drug effects Metformin/therapeutic use Nitriles/adverse effects Nitriles/therapeutic use Protease Inhibitors/therapeutic use Pyrazines/adverse effects Pyrazines/therapeutic use Pyrrolidines/adverse effects Pyrrolidines/therapeutic use Substrate Specificity Thiazolidinediones/therapeutic use Triazoles/adverse effects Triazoles/therapeutic use | Type 2/drug therapy Drug Therapy | Klinisk medicin | CD26/antagonists & inhibitors Body Weight/drug effects Diabetes Mellitus
Journal Article
Diabetes Care, ISSN 0149-5992, 2009, Volume 32, Issue 5, pp. 762 - 768
0.0001). beta-Cell function measures returned to pretreatment values in both groups after a 4-week off-drug period. A1C and body weight rose to pretreatment... 
NON-INFERIORITY | GLYCEMIC CONTROL | SULFONYLUREA | GLUCAGON-LIKE PEPTIDE-1 | EXENDIN-4 | BASAL INSULIN | GLUCOSE | ENDOCRINOLOGY & METABOLISM | SECRETION | MELLITUS | TWICE-DAILY EXENATIDE | Metformin - therapeutic use | C-Peptide - blood | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Male | Exenatide | Female | Insulin - analogs & derivatives | Insulin Secretion | Body Mass Index | Hypoglycemic Agents - therapeutic use | Insulin-Secreting Cells - physiology | Insulin, Long-Acting | Diabetes Mellitus, Type 2 - blood | Insulin - metabolism | Diabetes Mellitus, Type 2 - physiopathology | Insulin-Secreting Cells - drug effects | Insulin Glargine | Arginine - pharmacology | Venoms - therapeutic use | Kinetics | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Insulin - therapeutic use | Peptides - therapeutic use | Index Medicus | Original Research | Hemoglobin A | Insulin/analogs & derivatives/secretion/therapeutic use | Blood Glucose/metabolism | Type 2/blood/drug therapy/physiopathology | MEDICIN OCH HÄLSOVETENSKAP | Diabetes Mellitus | Insulin-Secreting Cells/drug effects/physiology | Venoms/therapeutic use | Metformin/therapeutic use | Glycosylated/metabolism | Peptides/therapeutic use | Arginine/pharmacology | Hypoglycemic Agents/therapeutic use | C-Peptide/blood | MEDICAL AND HEALTH SCIENCES
Journal Article
Drug Discovery Today, ISSN 1359-6446, 09/2013, Volume 18, Issue 17-18, pp. 807 - 817
Journal Article
Nature Reviews Endocrinology, ISSN 1759-5029, 10/2016, Volume 12, Issue 10, pp. 566 - 592
Journal Article